New awards, FY2016-17
Major funding
William Hawkins, MD
Division of General Surgery, Section of Hepatobiliary-Pancreatic and Gastrointestinal Surgery
$10,362,953
NIH SPORE/Washington University SPORE in Pancreatic Cancer (P50CA196510) 07/28/16-06/30/21
The Specialized Programs of Research Excellence (SPORE) grant is a cornerstone of the National Cancer Institute’s efforts to promote collaborative, interdisciplinary translational cancer research. This SPORE grant involves both basic and clinical/applied scientists working together and supports projects that will result in new and diverse approaches to the prevention, early detection, diagnosis and treatment of pancreatic cancer.
Alana Desai, MD, and Henry Lai, MD
Division of Urologic Surgery
$3,399,499
NIH U01/1/1 Urinary Stone Disease Washington University Research Network (U01DK110986) 07/01/06-06/30/18
This grant establishes a multicenter, multidisciplinary group of investigators known as the Urinary Stone Disease Research Network (USDRN). Washington University is one of these centers, which will look at the impact of increased fluid intake and increased urine output on the rate of recurrence of urinary stones, conduct research to understand and mitigate ureteral stent-related pain and symptoms, and provide data and collect biological samples from the studies to create a resource for future researchers.
Ryan Fields, MD
Division of General Surgery, Section of Hepatobiliary-Pancreatic and Gastrointestinal Surgery
$1,816,168
NIH R01/Towards True Precision Oncology: Validation of a Comprehensively Humanized, Autologous Mouse Model (R01CA204115) 01/09/17-12/31/19
Fields and a multidisciplinary research team are developing a mouse model that could enable cancer specialists to test how an individual person’s tumor responds to specific therapies. The lab is testing the model in melanoma patients, but eventually it could be applied to all cancers.
Vetta Thompson, PhD
Division of Public Health Sciences
$1,030,161
Patient-Centered Outcomes Research Institute (PCORI)/Developing and Validating Quantitative Measures to Assess Community Engagement in Research: Addressing the Measurement Challenge (ME-1511-33027) 02/01/17-01/31/20
Thompson, co-PI, and researchers use community-engaged research approaches and mixed methods (e.g. qualitative/quantitative) research techniques to develop and validate comprehensive (long) and condensed (shorter) survey instruments that assess the level of community engagement in research studies from the stakeholder perspective.
Additional funding
Cardiothoracic Surgery
Andrew Gelman, PhD
Section of General Thoracic Surgery
$176,265
Quark (Industry)/The Evaluation of Quark siRNA in Mouse Lung Transplants 06/27/2017-06/23/2018
General Surgery
Dirk Spitzer, PhD
Section of Hepatobiliary-Pancreatic and Gastrointestinal Surgery
$686,236
Department of Defense/U.S. Army/New-Generation Precision Medicines: Biomarker-Targeted TR3 Biologics Overcome Treatment Resistance in Ovarian Cancer (W81XWH-17-1-0102) 04/01/17-03/31/20
William Gillanders, MD
Section of Endocrine and Oncologic Surgery
$400,000
Siteman Investment Program Pre-SPORE/Siteman Cancer Center Breast Cancer SPORE (competitive second year) 01/01/17-12/31/17
William Hawkins, MD
Section of Hepatobiliary-Pancreatic and Gastrointestinal Surgery
$150,537
Pancreatic Cancer Action Network (PanCAN)/Targeting Tumor Infiltrating Myeloid Cells to Enhance Immunotherapy (16-65-HAWK) 07/01/16-06/30/18
Mohamed Zayed, MD, PhD
Section of Vascular Surgery
$150,000
Society for Vascular Surgery Foundation/Mentored Clinical Scientist Research Career Development Award 06/01/17-05/31/20
Plastic and Reconstructive Surgery
Alison Snyder-Warwick, MD
$717,332
NIH K08/Investigation of Terminal Schwann Cell Function in Homeostasis and Injury (K08NS096232) 04/01/17-03/31/21
Katherine Santosa, MD
$121,980
NIH F32/Molecular Mechanisms of Terminal Schwann Cell Response After Nerve Injury (F32NS098561) 07/01/16-06/30/18
Plastic and Reconstructive Surgery/Public Health Sciences
Terence Myckatyn, MD (Plastic Surgery) and Mary Politi, PhD (Public Health Sciences)
$400,000
Siteman Investment Program Multi-PI Pre-R01/ Optimizing Decision Making About Breast Reconstruction After Mastectomy: A Patient- Centered Approach 01/01/17-12/31/18
Public Health Sciences
Erin Linnenbringer, PhD
$543,275
NIH K07/Integration of Genomic and Social Science in Breast Cancer Disparities Research (K07CA212032) 09/15/06-08/31/20